Altered peptide ligands regulate type II collagen-induced arthritis in mice

Modern Rheumatology

Volumn 19, Issue 4, 2009, Pages 366-371

  Wakamatsu, Ei ^a   Matsumoto, Isao ^a   Yoshiga, Yohei ^a   Hayashi, Taichi ^a   Goto, Daisuke ^a   Ito, Satoshi ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Altered peptide ligand; Antagonist; T cells; Type II collagen induced arthritis

Indexed keywords

ALTERED PEPTIDE LIGAND; ALTERED PEPTIDE LIGAND 1; ALTERED PEPTIDE LIGAND 2; ALTERED PEPTIDE LIGAND 3; ALTERED PEPTIDE LIGAND 4; ALTERED PEPTIDE LIGAND 5; ALTERED PEPTIDE LIGAND 6; ALTERED PEPTIDE LIGAND 7; ALTERED PEPTIDE LIGAND 8; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; COLLAGEN TYPE 2; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG MECHANISM; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELLS, CULTURED; COLLAGEN TYPE II; INTERLEUKIN-17; LIGANDS; MICE; MICE, INBRED DBA; PEPTIDE FRAGMENTS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTES;

EID: 68549117150     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-009-0174-0     Document Type: Article

References (16)

1. Struyk L, Hawes GE, Dolhain RJ, van Scherpenzeel A, Godthelp B, Breedveld FC, et al. Evidence for selective in vivo expansion of synovial tissue-infiltrating CD4+CD45RO+T lymphocyte on the basis of CDR3 diversity. Int Immunol. 1994;6:897-907.
2. Fugger L, Svejgaard A. Association of MHC and rheumatoid arthritis. HLA-DR4 and rheumatoid arthritis: Studies in mice and human. Arthritis Res Ther. 2000;2:208-11.
3. Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Duance V, et al. Persistence of collagen type II-specific T cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA. 1989;86:636-40.
4. Saeki T, Kato T, Masuko-Hongo K, Nakamura H, Yoshino S, Nishioka K, et al. Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58:446-50.
5. Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology. 2001;103:407-16.
6. Magistris MTD, Alexander J, Coggeshall M, Altman A, Gaeta FC, Grey HM, et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell. 1992;68:625-34.
7. Pfeiffer C, Stein J, Aouthwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 1995;181:1569-74.
8. Ohnishi Y, Tsutsumi A, Matsumoto I, Goto D, Ito S, Kuwana M, et al. Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients. Mod Rheumatol. 2006;16:226-8.
9. Wraith DC, Smilek DE, Mitchell DJ, Steinman L, McDevitt HO. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 1989;59:247-55.
10. Myers LK, Rosloniec EF, Seyer JM, Stuart JM, Kang AH. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis. J Immunol. 1993;150:4652-8.
11. Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat Rev Immunol. 2007;7:665-77.
12. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003;171:6173-7.
13. Myers LK, Tang B, Rosloniec EF, Stuart JM, Chiang TM, Kang AH. Characterization of a peptide analogue of a determinant of type II collagen that suppress collagen-induced arthritis. J Immunol. 1998;161:3589-95.
14. Zhao J, Li R, He J, Shi J, Long L, Li Z. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells. Rheumatol Int. 2008;29:9-16.
15. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol. 1997;158:5507-13.
16. Coppieters K, Van Beneden K, Jacques P, Dewint P, Vervloet A, Vander Cruyssen B, et al. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in ligand-specific manner. J Immunol. 2007;179:2300-9.